DTB Podcast

September 2016: Last orders for nalmefene in the management of alcohol dependence?

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the use of nalmefene in the management of alcohol dependence. Although the drug has been approved for use in the NHS, DTB's editorial highlights limitations of the evidence supporting its use and discusses concerns raised by three groups of researchers. Currently, the NHS in England spends £20,000 per month on the drug in primary care.
Read the full editorial here: http://dtb.bmj.com/content/54/9/97.full.
There’s also a review of the management of hidradenitis suppurativa. Article accessible here: http://dtb.bmj.com/content/54/9/102.full.
The DTB editors also talk about the benefits and limitations of observational studies. Article accessible here: http://dtb.bmj.com/content/54/9/105.full.

August 2016: Better guidelines. Capsaicin for diabetic neuropathy. Excipients in medicines

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the presentation of guidelines and ways of making them more accessible. Read the full editorial here: http://dtb.bmj.com/content/54/8/85.full
There’s also an evaluation of the use of capsaicin for diabetic peripheral neuropathy. Article accessible here: http://dtb.bmj.com/content/54/8/90.full
The DTB editors also talk about medicines, excipients and dietary intolerances. Article accessible here: http://dtb.bmj.com/content/54/8/93.full

July 2016: Where next for rationing medicines? Vitamins during pregnancy: a big marketing campaign?

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss proposals to stop the prescription of some medicines and foods in order to help manage the deficit in NHS budgets. Full article available here: http://dtb.bmj.com/content/early/2016/07/07/dtb.2016.7.0409.full.
The podcast also includes a review of an article about the effects of the antidiabetic drug empagliflozin on cardiovascular outcomes, as well as a review of an article on the use of vitamin supplementation during pregnancy. Read this article here: http://dtb.bmj.com/content/early/2016/07/11/dtb.2016.7.0414.full.

June 2016: Problems with botanicals; a new drug for heart failure; frailty and deprescribing

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the use of herbal products. They also develop the highlights of the articles: Articles: "Frailty, polypharmacy and deprescribing" and "Sacubitril valsartan for heart failure"
Read all the articles featured here: dtb.bmj.com/content/54/6.toc

May 2016: supporting learning disabilities; new drugs for orthostatic hypotension and ADHD

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss health checks for young people with learning disabilities and review two recently licensed drugs - one for treating orthostatic hypotension and the other for managing ADHD in children and adolescents.
Read all the articles featured here: dtb.bmj.com/content/54/5.toc

April 2016: the cancer drugs fund for England, restless legs and animal-derived content in medicines

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the Cancer Drug Fund for England; review a new indication for the combination of oxycodone and naloxone for the management of restless legs syndrome; and consider the impact of animal-derived medicines.
Read the articles featured here:
Editorial: NICE and the cancer drugs fund for England
Articles: 1. Targinact for restless legs syndrome 2. Implications of religious and cultural beliefs on selection of medicines

March 2016 Issue: Testosterone replacement therapy and a new antidepressant

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss testosterone replacement therapy; review the new antidepressant vortioxetine; and consider the impact of drugs on the QT interval.
The DTB podcast is recorded monthly to coincide with the release of the print issue of DTB.
Read all the articles featured here: dtb.bmj.com/content/54/3.toc

February 2016 issue: Too many options, too little choice in COPD?

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the proliferation of new drugs for managing COPD; review two new lipid-lowering drugs (evolocumab and alirocumab) from a new class (proprotein convertase subtilisin/kexin type 9 inhibitors); and consider total ankle joint replacement.
The DTB podcast is recorded monthly to coincide with the release of the print issue of DTB.
Read all the articles featured here: http://dtb.bmj.com/content/54/2.toc

January 2016 issue: NHS Health Checks, Adolescent Adherence and Management of Dry Eye

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss NHS Health Checks in England; the challenges facing young people taking medicines for long-term conditions; and the management of dry eye disease.
The DTB podcast is recorded monthly to coincide with the release of the print issue of DTB.
Read all the articles featured here: http://dtb.bmj.com/content/54/1.toc

December 2015 issue: Cost-effectiveness of drugs on long term conditions

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss stopping rules for medicines used to manage long-term conditions; naloxegol for the management of opioid-induced constipation that has failed to respond to laxative therapy; and the plethora of new drugs and preparations for the management of open-angle glaucoma in adults.
The DTB podcast is recorded monthly to coincide with the release of the print issue of DTB.
Read all the articles featured here: http://dtb.bmj.com/content/53/12.toc